placeholder newsslider


Glaukos Expands its Preserflo MicroShunt Relationship With Santen via New License Agreement

Glaukos announced that it has entered into a new development and commercialization license agreement with Santen Pharmaceutical for the Preserflo MicroShunt (development code: DE-128), superseding the previous collaboration and distribution agreements between the two parties.

‘Hybrid’ scientific conferences aim to offer the best of in-person and virtual meetings

Last year, the COVID-19 pandemic upended the conference experience for researchers around the globe as scientific societies canceled in-person meetings and scrambled to hold virtual events in their place—with varying success.

Even in a pandemic, child vision tests are crucial

It's critical for parents to maintain their children's vision checkups during the COVID-19 pandemic, an expert says.

FDA Approves Bausch + Lomb ClearVisc Dispersive Ophthalmic Viscosurgical Device (OVD)

Bausch + Lomb, announced that the FDA has approved ClearVisc dispersive ophthalmic viscosurgical device (OVD) for use in ophthalmic surgery.

Norwegian government proposes changes to university legislation

Lecturers’ union welcomes move to simplify reporting of sexual harassment and protect academic freedom. A proposed change to Norway’s university governance law could improve how sexual harassment is reported, how exams are monitored and how academic freedom is protected.

Computer Model Fosters Potential Improvements to ‘Bionic Eye’ Technology

There are millions of people who face the loss of their eyesight from degenerative eye diseases. The genetic disorder retinitis pigmentosa alone affects 1 in 4,000 people worldwide.

Allergan Launches New Consumer Ad Campaign for Restasis

Allergan announced it is launching a direct-to-consumer (DTC) broadcast TV advertising campaign for Restasis (cyclosporine ophthalmic emulsion) 0.05%, launching April 2021.

Open access at Denmark’s universities tops 60%

All universities have increased or maintained their share of open-access articles in the past year. Three universities in Denmark have exceeded this year’s target of publishing 63 per cent of scientific articles in an open-access format, according to the sixth edition of the Danish open-access indicator.

Eye care is key when you're working from home

If you're one of the many people who've switched to working at home during the COVID-19 pandemic, you need to take care of your eyes, the American Academy of Ophthalmology says.

Ocuphire Initiates ZETA-1 Phase 2 Clinical Trial Investigating APX3330 in Diabetic Retinopathy

Ocuphire Pharma announced that it has screened the first patient in ZETA-1, a phase 2 trial to evaluate APX3330 in non-proliferative diabetic retinopathy (NPDR) and mild proliferative diabetic retinopathy (PDR). Effects on diabetic macular edema will be explored as a secondary outcome. A number of retinal centers across the US are active and recruiting eligible diabetic retinopathy patients.

Biden wants $6.5 billion for new health agency to speed treatments

The Biden administration began to flesh out a proposal for a new agency—modeled on the military’s Defense Advanced Research Projects Agency (DARPA)—that would seek to speed the development of medical treatments by funding risky, innovative projects. The agency, dubbed ARPA-Health (ARPA-H), would be housed at the National Institutes of Health and have a 2022 budget of $6.5 billion.

Santen Announces Global Research Initiative to Study and Develop New Treatments for Glaucoma

Santen announced a research initiative with scientists from Massachusetts Eye and Ear, and Ulster University, UK, to research and develop novel treatments for glaucoma.

UK announces €250M towards Horizon Europe participation cost following scientist revolt

Government comes up with 11th hour funds to help meet association cost after lobbying effort by science leaders. But critics still call plan ‘very opaque’, and say it isn’t enough

Alcon Canada Introduces UV Only IOLs for AcrySof IQ PanOptix and AcrySof IQ Vivity Portfolios

Alcon has announced the availability of AcrySof IQ PanOptix UV IOL, AcrySof IQ PanOptix Toric UV IOL, AcrySof IQ Vivity UV IOL, and AcrySof IQ Vivity Toric UV IOL as part of the presbyopia-correcting lens portfolio in Canada.

European Innovation Council opens €1B funding round for start-ups

Small and medium-sized companies can apply for grants of up to €2.5M and direct equity investments of up to €15M in the first calls